Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Michelangelo Fiorentino, Ph.D., M.D.

Title
Institution
Department
Address
Phone

Bibliographic
selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Di Sciascio L, Ambrosi F, Franceschini T, Giunchi F, Franchini E, Massari F, Bianchi FM, Colecchia M, Fiorentino M, Ricci C. Could double stain for p53/CK20 be a useful diagnostic tool for the appropriate classification of flat urothelial lesions? Pathol Res Pract. 2022 Jun; 234:153937. PMID: 35561522.
    Citations:    Fields:    
  2. Ricci C, Franceschini T, Giunchi F, Grillini M, Ambrosi F, Massari F, Mollica V, Colecchia M, Fiorentino M. Immunohistochemical Expression of Preferentially Expressed Antigen in Melanoma (PRAME) in the Uninvolved Background Testis, Germ Cell Neoplasia In Situ, and Germ Cell Tumors of the Testis. Am J Clin Pathol. 2022 05 04; 157(5):644-648. PMID: 34864837.
    Citations:    Fields:    Translation:Humans
  3. Ambrosi F, Giunchi F, Capizzi E, Cancellieri A, Trisolini R, Ardizzoni A, Fiorentino M, Ricci C. Interobserver agreement of PD-L1 (SP263) assessment in advanced NSCLC on cytological smears and histological samples. Pathol Res Pract. 2022 May; 233:153893. PMID: 35429890.
    Citations:    Fields:    Translation:Humans
  4. Ricci C, Dika E, Lambertini M, Ambrosi F, Grillini M, Chillotti S, Corradini AG, Veronesi G, Fiorentino M, Corti B. Hematoxylin and eosin or double stain for CD34/SOX10: Which is better for the detection of lymphovascular invasion in cutaneous melanoma? Pathol Res Pract. 2022 May; 233:153876. PMID: 35390633.
    Citations:    Fields:    Translation:Humans
  5. Gaudiano C, Ciccarese F, Bianchi L, Corcioni B, De Cinque A, Giunchi F, Schiavina R, Fiorentino M, Brunocilla E, Golfieri R. The role of MRI in the detection of local recurrence: Added value of multiparametric approach and Signal Intensity/Time Curve analysis. Arch Ital Urol Androl. 2022 Mar 28; 94(1):25-31. PMID: 35352521.
    Citations:    Fields:    Translation:Humans
  6. Ricci C, Dika E, Lambertini M, Ambrosi F, Chiarucci F, Chillotti S, Fiorentino M, Fabbri E, Tassone D, Veronesi G, Tartari F, Corti B. The EORTC protocol for sentinel lymph node biopsy (SLNB) reveals a high number of nodal nevi and a strong association with nevus-associated melanoma. Pathol Res Pract. 2022 May; 233:153805. PMID: 35361504.
    Citations:    Fields:    Translation:Humans
  7. Cambuli F, Foletto V, Alaimo A, De Felice D, Gandolfi F, Palumbieri MD, Zaffagni M, Genovesi S, Lorenzoni M, Celotti M, Bertossio E, Mazzero G, Bertossi A, Bisio A, Berardinelli F, Antoccia A, Gaspari M, Barbareschi M, Fiorentino M, Shen MM, Loda M, Romanel A, Lunardi A. Intra-epithelial non-canonical Activin A signaling safeguards prostate progenitor quiescence. EMBO Rep. 2022 05 04; 23(5):e54049. PMID: 35253958.
    Citations:    Fields:    Translation:AnimalsCells
  8. Gaudiano C, Rustici A, Corcioni B, Ciccarese F, Bianchi L, Schiavina R, Giunchi F, Fiorentino M, Brunocilla E, Golfieri R. PI-RADS version 2.1 for the evaluation of transition zone lesions: a practical guide for radiologists. Br J Radiol. 2022 Mar 01; 95(1131):20210916. PMID: 34919421.
    Citations: 2     Fields:    Translation:Humans
  9. Zelic R, Giunchi F, Fridfeldt J, Carlsson J, Davidsson S, Lianas L, Mascia C, Zugna D, Molinaro L, Vincent PH, Zanetti G, Andrén O, Richiardi L, Akre O, Fiorentino M, Pettersson A. Prognostic Utility of the Gleason Grading System Revisions and Histopathological Factors Beyond Gleason Grade. Clin Epidemiol. 2022; 14:59-70. PMID: 35082531.
    Citations: 1     
  10. Ricci AD, Rizzo A, Mollica V, Schiavina R, Fiorentino M, Brunocilla E, Ardizzoni A, Massari F. Platinum-based adjuvant chemotherapy for upper tract urothelial carcinoma: a change of paradigm? A meta-analysis of aggregate data. Anticancer Drugs. 2022 01 01; 33(1):e61-e68. PMID: 34387596.
    Citations:    Fields:    Translation:Humans
  11. Grillini M, Ricci C, Pino V, Pedrini S, Fiorentino M, Corti B. HMB45/PRAME, a Novel Double Staining for the Diagnosis of Melanocytic Neoplasms: Technical Aspects, Results, and Comparison With Other Commercially Available Staining (PRAME and Melan A/PRAME). Appl Immunohistochem Mol Morphol. 2022 01 01; 30(1):14-18. PMID: 34508017.
    Citations: 2     Fields:    Translation:Humans
  12. Stopsack KH, Tyekucheva S, Wang M, Gerke TA, Vaselkiv JB, Penney KL, Kantoff PW, Finn SP, Fiorentino M, Loda M, Lotan TL, Parmigiani G, Mucci LA. Extent, impact, and mitigation of batch effects in tumor biomarker studies using tissue microarrays. Elife. 2021 12 23; 10. PMID: 34939926.
    Citations:    Fields:    Translation:Humans
  13. Dorofte L, Grélaud D, Fiorentino M, Giunchi F, Ricci C, Franceschini T, Riefolo M, Davidsson S, Carlsson J, Lillsunde Larsson G, Karlsson MG. Low level of interobserver concordance in assessing histological subtype and tumor grade in patients with penile cancer may impair patient care. Virchows Arch. 2022 Apr; 480(4):879-886. PMID: 34889977.
    Citations:    Fields:    Translation:Humans
  14. Gaudiano C, Bianchi L, De Cinque A, Corcioni B, Giunchi F, Schiavina R, Fiorentino M, Brunocilla E, Golfieri R. The impact of multiparametric MRI features to identify the presence of prevalent cribriform pattern in the peripheral zone tumors. Radiol Med. 2022 Feb; 127(2):174-182. PMID: 34850354.
    Citations: 1     Fields:    Translation:Humans
  15. De Maglio G, Pasello G, Dono M, Fiorentino M, Follador A, Sciortino M, Malapelle U, Tiseo M. The storm of NGS in NSCLC diagnostic-therapeutic pathway: How to sun the real clinical practice. Crit Rev Oncol Hematol. 2022 Jan; 169:103561. PMID: 34856311.
    Citations: 1     Fields:    Translation:Humans
  16. Gaudiano C, Bianchi L, Corcioni B, Giunchi F, Schiavina R, Ciccarese F, Braccischi L, Rustici A, Fiorentino M, Brunocilla E, Golfieri R. Evaluating the performance of clinical and radiological data in predicting prostate cancer in prostate imaging reporting and data system version 2.1 category 3 lesions of the peripheral and the transition zones. Int Urol Nephrol. 2022 Feb; 54(2):263-271. PMID: 34822065.
    Citations:    Fields:    Translation:Humans
  17. Ricci C, Franceschini T, Giunchi F, Borsato M, Mollica V, Massari F, Fiorentino M. A preliminary study investigating the detection of lymphovascular invasion in germ cell tumors of the testis with double staining for OCT4/CD34. Pathol Res Pract. 2021 Nov; 227:153637. PMID: 34619577.
    Citations:    Fields:    Translation:Humans
  18. Bianchi L, Chessa F, Angiolini A, Cercenelli L, Lodi S, Bortolani B, Molinaroli E, Casablanca C, Droghetti M, Gaudiano C, Mottaran A, Porreca A, Golfieri R, Romagnoli D, Giunchi F, Fiorentino M, Piazza P, Puliatti S, Diciotti S, Marcelli E, Mottrie A, Schiavina R. The Use of Augmented Reality to Guide the Intraoperative Frozen Section During Robot-assisted Radical Prostatectomy. Eur Urol. 2021 10; 80(4):480-488. PMID: 34332759.
    Citations:    Fields:    Translation:Humans
  19. Zanoni L, Bianchi L, Nanni C, Pultrone C, Giunchi F, Bossert I, Matti A, Schiavina R, Fiorentino M, Romagnoli D, Fonti C, Lodi F, D'Errico A, Brunocilla E, Porreca A, Fanti S. [18F]-Fluciclovine PET/CT for preoperative nodal staging in high-risk primary prostate cancer: final results of a prospective trial. Eur J Nucl Med Mol Imaging. 2021 12; 49(1):390-409. PMID: 34213609.
    Citations: 1     Fields:    Translation:HumansCTClinical Trials
  20. Marchetti A, Rosellini M, Mollica V, Rizzo A, Tassinari E, Nuvola G, Cimadamore A, Santoni M, Fiorentino M, Montironi R, Massari F. The Molecular Characteristics of Non-Clear Cell Renal Cell Carcinoma: What's the Story Morning Glory? Int J Mol Sci. 2021 Jun 09; 22(12). PMID: 34207825.
    Citations:    Fields:    Translation:Humans
  21. Ricci C, Ambrosi F, Dika E, Lambertini M, Chillotti S, Fiorentino M, Corti B. Giant (pseudo) vascular spiradenoma: a case report of an extremely rare entity with the immuno-histological demonstration of the coexistence of vascular and pseudo-vascular components. Ital J Dermatol Venerol. 2021 Oct; 156(5):630-632. PMID: 33890732.
    Citations:    Fields:    Translation:Humans
  22. Rizzo A, Mollica V, Rosellini M, Marchetti A, Ricci AD, Fiorentino M, Battelli N, Santoni M, Massari F. Exploring the association between metastatic sites and androgen receptor splice variant 7 (AR-V7) in castration-resistant prostate cancer patients: A meta-analysis of prospective clinical trials. Pathol Res Pract. 2021 Jun; 222:153440. PMID: 33857854.
    Citations: 1     Fields:    Translation:HumansCells
  23. Livi V, Paioli D, Cancellieri A, Betti S, Natali F, Ferrari M, Fiorentino M, Trisolini R. Diagnosis and Molecular Profiling of Lung Cancer by Percutaneous Ultrasound-Guided Biopsy of Superficial Metastatic Sites Is Safe and Highly Effective. Respiration. 2021; 100(6):515-522. PMID: 33827098.
    Citations:    Fields:    Translation:Humans
  24. Zanoni L, Mei R, Bianchi L, Giunchi F, Maltoni L, Pultrone CV, Nanni C, Bossert I, Matti A, Schiavina R, Fiorentino M, Fonti C, Lodi F, D'Errico A, Brunocilla E, Fanti S. The Role of [18F]Fluciclovine PET/CT in the Characterization of High-Risk Primary Prostate Cancer: Comparison with [11C]Choline PET/CT and Histopathological Analysis. Cancers (Basel). 2021 Mar 29; 13(7). PMID: 33805543.
    Citations: 1     
  25. Borghesi M, Bianchi L, Barbaresi U, Vagnoni V, Corcioni B, Gaudiano C, Fiorentino M, Giunchi F, Chessa F, Garofalo M, Bertaccini A, Angelini S, Ercolino A, Casablanca C, Droghetti M, Golfieri R, Schiavina R. Diagnostic performance of MRI/TRUS fusion-guided biopsies vs. systematic prostate biopsies in biopsy-naïve, previous negative biopsy patients and men undergoing active surveillance. Minerva Urol Nephrol. 2021 Jun; 73(3):357-366. PMID: 33769008.
    Citations: 3     Fields:    Translation:Humans
  26. Rizzo A, Mollica V, Giunchi F, Dall'Olio FG, Rosellini M, Marchetti A, Franceschini T, Schiavina R, Brunocilla E, Fiorentino M, Ardizzoni A, Massari F. Impact of HER2 assessment by CISH in urothelial carcinoma: A retrospective single-center experience. Pathol Res Pract. 2021 Apr; 220:153410. PMID: 33765474.
    Citations:    Fields:    Translation:Humans
  27. Dall'Olio FG, Gelsomino F, Conci N, Marcolin L, De Giglio A, Grilli G, Sperandi F, Fontana F, Terracciano M, Fragomeno B, Tober N, Manferrari G, Brocchi S, Golfieri R, Fiorentino M, Ardizzoni A. PD-L1 Expression in Circulating Tumor Cells as a Promising Prognostic Biomarker in Advanced Non-small-cell Lung Cancer Treated with Immune Checkpoint Inhibitors. Clin Lung Cancer. 2021 09; 22(5):423-431. PMID: 33849808.
    Citations: 7     Fields:    Translation:Humans
  28. Giunchi F, Franceschini T, Fiorentino M. A narrative review of individualized treatments of genitourinary tumors: is the future brighter with molecular evaluations? Transl Androl Urol. 2021 Mar; 10(3):1553-1561. PMID: 33850789.
    Citations: 2     
  29. Zelic R, Giunchi F, Lianas L, Mascia C, Zanetti G, Andrén O, Fridfeldt J, Carlsson J, Davidsson S, Molinaro L, Vincent PH, Richiardi L, Akre O, Fiorentino M, Pettersson A. Interchangeability of light and virtual microscopy for histopathological evaluation of prostate cancer. Sci Rep. 2021 02 05; 11(1):3257. PMID: 33547336.
    Citations: 2     Fields:    Translation:Humans
  30. Mollica V, Franceschini T, Gruppioni E, Rizzo A, Ricci C, Schiavina R, Brunocilla E, Ardizzoni A, Fiorentino M, Giunchi F, Massari F. Broad spectrum mutational analysis of chromophobe renal cell carcinoma using next-generation sequencing. Pathol Res Pract. 2021 Mar; 219:153350. PMID: 33556910.
    Citations: 1     Fields:    Translation:Humans
  31. Franceschini T, Giunchi F, Mollica V, Altimari A, Capizzi E, Banfi M, Schiavina R, Fiorentino M, Massari F. Renal Tumors with Oncocytic and Papillary Features: A Phenotypic and Genotypic Study. Diagnostics (Basel). 2021 Jan 28; 11(2). PMID: 33525402.
    Citations:    
  32. Pernar CH, Parmigiani G, Giovannucci EL, Rimm EB, Tyekucheva S, Loda M, Finn SP, Vander Heiden MG, Fiorentino M, Ebot EM, Mucci LA. Gene Expression Pathways in Prostate Tissue Associated with Vigorous Physical Activity in Prostate Cancer. Cancer Epidemiol Biomarkers Prev. 2021 04; 30(4):751-756. PMID: 33500320.
    Citations: 1     Fields:    Translation:Humans
  33. Mollica V, Rizzo A, Tassinari E, Giunchi F, Schiavina R, Fiorentino M, Brunocilla E, Ardizzoni A, Massari F. Prognostic and predictive factors to nivolumab in patients with metastatic renal cell carcinoma: a single center study. Anticancer Drugs. 2021 01 01; 32(1):74-81. PMID: 33290315.
    Citations:    Fields:    Translation:HumansCTClinical Trials
  34. Ambrosi F, Ricci C, Malvi D, Cillia C, Ravaioli M, Fiorentino M, Cardillo M, Vasuri F, D'Errico A. Pathological features and outcomes of incidental renal cell carcinoma in candidate solid organ donors. Kidney Res Clin Pract. 2020 Dec 31; 39(4):487-494. PMID: 32855366.
    Citations:    
  35. Giunchi F, Massari F, Altimari A, Gruppioni E, Nobili E, Fiorentino M, Ardizzoni A. Dual TMPRSS2:ERG Fusion in a Patient with Lung and Prostate Cancers. Diagnostics (Basel). 2020 Dec 20; 10(12). PMID: 33419298.
    Citations:    
  36. Ricci C, Capizzi E, Giunchi F, Casolari L, Gelsomino F, Rihawi K, Natali F, Livi V, Trisolini R, Fiorentino M, Ardizzoni A. Reliability of programmed death ligand 1 (PD-L1) tumor proportion score (TPS) on cytological smears in advanced non-small cell lung cancer: a prospective validation study. Ther Adv Med Oncol. 2020; 12:1758835920954802. PMID: 33299472.
    Citations: 1     
  37. Schiavina R, Droghetti M, Novara G, Bianchi L, Gaudiano C, Panebianco V, Borghesi M, Piazza P, Mineo Bianchi F, Guerra M, Corcioni B, Fiorentino M, Giunchi F, Verze P, Pultrone C, Golfieri R, Porreca A, Mirone V, Brunocilla E. The role of multiparametric MRI in active surveillance for low-risk prostate cancer: The ROMAS randomized controlled trial. Urol Oncol. 2021 07; 39(7):433.e1-433.e7. PMID: 33191117.
    Citations: 1     Fields:    Translation:Humans
  38. Penney KL, Tyekucheva S, Rosenthal J, El Fandy H, Carelli R, Borgstein S, Zadra G, Fanelli GN, Stefanizzi L, Giunchi F, Pomerantz M, Peisch S, Coulson H, Lis R, Kibel AS, Fiorentino M, Umeton R, Loda M. Metabolomics of Prostate Cancer Gleason Score in Tumor Tissue and Serum. Mol Cancer Res. 2021 03; 19(3):475-484. PMID: 33168599.
    Citations: 3     Fields:    Translation:Humans
  39. Damiani S, Fiorentino M, De Palma A, Foschini MP, Lazzarotto T, Gabrielli L, Viale PL, Attard L, Riefolo M, D'Errico A. Pathological post-mortem findings in lungs infected with SARS-CoV-2. J Pathol. 2021 01; 253(1):31-40. PMID: 32930394.
    Citations: 24     Fields:    Translation:HumansCells
  40. Colecchia M, Bertolotti A, Paolini B, Giunchi F, Necchi A, Paganoni AM, Ricci C, Fiorentino M, Dagrada GP. The Leydig cell tumour Scaled Score (LeSS): a method to distinguish benign from malignant cases, with additional correlation with MDM2 and CDK4 amplification. Histopathology. 2021 Jan; 78(2):290-299. PMID: 32757426.
    Citations:    Fields:    Translation:Humans
  41. Rizzo A, Mollica V, Cimadamore A, Santoni M, Scarpelli M, Giunchi F, Cheng L, Lopez-Beltran A, Fiorentino M, Montironi R, Massari F. Is There a Role for Immunotherapy in Prostate Cancer? Cells. 2020 09 08; 9(9). PMID: 32911806.
    Citations: 10     Fields:    Translation:Humans
  42. Schiavina R, Bianchi L, Lodi S, Cercenelli L, Chessa F, Bortolani B, Gaudiano C, Casablanca C, Droghetti M, Porreca A, Romagnoli D, Golfieri R, Giunchi F, Fiorentino M, Marcelli E, Diciotti S, Brunocilla E. Real-time Augmented Reality Three-dimensional Guided Robotic Radical Prostatectomy: Preliminary Experience and Evaluation of the Impact on Surgical Planning. Eur Urol Focus. 2021 Nov; 7(6):1260-1267. PMID: 32883625.
    Citations: 8     Fields:    Translation:Humans
  43. Davidsson S, Fiorentino M, Giunchi F, Eriksson M, Erlandsson A, Sundqvist P, Carlsson J. Infiltration of M2 Macrophages and Regulatory T Cells Plays a Role in Recurrence of Renal Cell Carcinoma. Eur Urol Open Sci. 2020 Jul; 20:62-71. PMID: 34337459.
    Citations: 3     
  44. Mollica V, Maggio I, Lopez-Beltran A, Montironi R, Cimadamore A, Cheng L, Rizzo A, Giunchi F, Schiavina R, Fiorentino M, Brunocilla E, Massari F. Combination therapy in advanced urothelial cancer: the role of PARP, HER-2 and mTOR inhibitors. Expert Rev Anticancer Ther. 2020 09; 20(9):755-763. PMID: 32757789.
    Citations: 2     Fields:    Translation:Humans
  45. Ricci C, Ambrosi F, Grillini M, Serra M, Melotti B, Gruppioni E, Altimari A, Fiorentino M, Dika E, Lambertini M, Corti B. Next-generation sequencing revealing TP53 mutation as potential genetic driver in dermal deep-seated melanoma arising in giant congenital nevus in adult patients: A unique case report and review of the literature. J Cutan Pathol. 2020 Dec; 47(12):1164-1169. PMID: 32643812.
    Citations: 1     Fields:    Translation:Humans
  46. Trisolini R, Cancellieri A, Livi V, Annema JT, Ferrari M, Natali F, Paioli D, Conci N, Altimari A, Fiorentino M, Ardizzoni A. Pulmonary adenocarcinoma with psammoma bodies is associated with a specific endobronchial ultrasound pattern and a high prevalence of actionable driver mutations. Lung Cancer. 2020 09; 147:204-208. PMID: 32736279.
    Citations:    Fields:    Translation:Humans
  47. Lamberti G, Gelsomino F, Brocchi S, Poerio A, Melotti B, Sperandi F, Gargiulo M, Borghi C, Fiorentino M, Ardizzoni A. New disappearance of complicated atheromatous plaques on rechallenge with PD-1/PD-L1 axis blockade in non-small cell lung cancer patient: follow up of an unexpected event. Ther Adv Med Oncol. 2020; 12:1758835920913801. PMID: 32782484.
    Citations: 3     
  48. Gelsomino F, Lamberti G, Tiseo M, Rocco D, Pasello G, Cecere FL, Chella A, Grilli G, Mandruzzato M, Tognetto M, Garassino MC, Macerelli M, Novello S, Roila F, Colantonio I, Grossi F, Fiorentino M, Ardizzoni A. Atezolizumab in a CoHort of pretreated, advanced, non-small cell lung cancer patients with rare HistologiCal SubtypEs (CHANCE trial). Ther Adv Med Oncol. 2020; 12:1758835920915983. PMID: 32733604.
    Citations: 2     
  49. Stopsack KH, Gerke T, Zareba P, Pettersson A, Chowdhury D, Ebot EM, Flavin R, Finn S, Kantoff PW, Stampfer MJ, Loda M, Fiorentino M, Mucci LA. Tumor protein expression of the DNA repair gene BRCA1 and lethal prostate cancer. Carcinogenesis. 2020 07 14; 41(7):904-908. PMID: 32556091.
    Citations:    Fields:    Translation:HumansCells
  50. Fankhauser CD, Penney KL, Gonzalez-Feliciano AG, Clarke NW, Hermanns T, Stopsack KH, Fiorentino M, Loda M, Mahal B, Gerke TA, Preston MA, Mucci LA. Inferior Cancer Survival for Men with Localized High-grade Prostate Cancer but Low Prostate-specific Antigen. Eur Urol. 2020 10; 78(4):637-639. PMID: 32624279.
    Citations: 2     Fields:    Translation:Humans
  51. Natali F, Cancellieri A, Giunchi F, De Silvestri A, Livi V, Ferrari M, Paioli D, Betti S, Fiorentino M, Trisolini R. Interobserver agreement between pathologist, pulmonologist and molecular pathologist to estimate the tumour burden in rapid on-site evaluation smears from endosonography and guided bronchoscopy. Cytopathology. 2020 07; 31(4):303-309. PMID: 32463969.
    Citations:    Fields:    Translation:Humans
  52. Droghetti M, Ercolino A, Piazza P, Bianchi L, Fabbrizio B, Giunchi F, Mineo Bianchi F, Barbaresi U, Casablanca C, Tonin E, Mottaran A, Fiorentino M, Schiavina R, Brunocilla E. Secondary bladder amyloidosis due to Crohn's disease: a case report and literature review. CEN Case Rep. 2020 11; 9(4):413-417. PMID: 32572782.
    Citations:    Fields:    Translation:Humans
  53. Mollica V, Rizzo A, Montironi R, Cheng L, Giunchi F, Schiavina R, Santoni M, Fiorentino M, Lopez-Beltran A, Brunocilla E, Brandi G, Massari F. Current Strategies and Novel Therapeutic Approaches for Metastatic Urothelial Carcinoma. Cancers (Basel). 2020 Jun 02; 12(6). PMID: 32498352.
    Citations: 17     
  54. Franceschini T, Capizzi E, Massari F, Schiavina R, Fiorentino M, Giunchi F. Immunohistochemical over-expression of HER2 does not always match with gene amplification in invasive bladder cancer. Pathol Res Pract. 2020 Aug; 216(8):153012. PMID: 32703487.
    Citations: 2     Fields:    Translation:HumansCells
  55. Dika E, Veronesi G, Altimari A, Riefolo M, Ravaioli GM, Piraccini BM, Lambertini M, Campione E, Gruppioni E, Fiorentino M, Melotti B, Ferracin M, Patrizi A. BRAF, KIT, and NRAS Mutations of Acral Melanoma in White Patients. Am J Clin Pathol. 2020 04 15; 153(5):664-671. PMID: 32017841.
    Citations: 5     Fields:    Translation:Humans
  56. Cavazzoni A, Digiacomo G, Alfieri R, La Monica S, Fumarola C, Galetti M, Bonelli M, Cretella D, Barili V, Zecca A, Giovannetti E, Fiorentino M, Tiseo M, Petronini PG, Ardizzoni A. Pemetrexed Enhances Membrane PD-L1 Expression and Potentiates T Cell-Mediated Cytotoxicity by Anti-PD-L1 Antibody Therapy in Non-Small-Cell Lung Cancer. Cancers (Basel). 2020 Mar 12; 12(3). PMID: 32178474.
    Citations: 7     
  57. Minari R, Mazzaschi G, Bordi P, Gnetti L, Alberti G, Altimari A, Gruppioni E, Sperandi F, Parisi C, Guaitoli G, Bettelli S, Longo L, Bertolini F, Pagano M, Bonelli C, Tagliavini E, Nicoli D, Ubiali A, Zangrandi A, Trubini S, Proietto M, Fiorentino M, Tiseo M. Detection of EGFR-Activating and T790M Mutations Using Liquid Biopsy in Patients With EGFR-Mutated Non-Small-Cell Lung Cancer Whose Disease Has Progressed During Treatment With First- and Second-Generation Tyrosine Kinase Inhibitors: A Multicenter Real-Life Retrospective Study. Clin Lung Cancer. 2020 09; 21(5):e464-e473. PMID: 32276870.
    Citations: 7     Fields:    Translation:Humans
  58. Carlsson J, Sundqvist P, Kosuta V, Fält A, Giunchi F, Fiorentino M, Davidsson S. PD-L1 Expression is Associated With Poor Prognosis in Renal Cell Carcinoma. Appl Immunohistochem Mol Morphol. 2020 03; 28(3):213-220. PMID: 31058656.
    Citations: 12     Fields:    Translation:HumansCells
  59. Caliò A, Brunelli M, Segala D, Pedron S, Remo A, Ammendola S, Munari E, Pierconti F, Mosca A, Bollito E, Sidoni A, Fisogni S, Sacco C, Canu L, Sentinelli S, Fraccon AP, Fiorentino M, Scott C, Milella M, Porta C, Argani P, Martignoni G. Comprehensive analysis of 34 MiT family translocation renal cell carcinomas and review of the literature: investigating prognostic markers and therapy targets. Pathology. 2020 Apr; 52(3):297-309. PMID: 32107074.
    Citations: 6     Fields:    Translation:HumansCells
  60. Giunchi F, Franceschini T, Gruppioni E, Altimari A, Capizzi E, Massari F, Schiavina R, Brunelli M, Martignoni G, Fiorentino M. Similarities and Differences between Clear Cell Tubulo-Papillary and Conventional Clear Cell Renal Cell Carcinoma: A Comparative Phenotypical and Mutational Analysis. Diagnostics (Basel). 2020 02 23; 10(2). PMID: 32102250.
    Citations: 2     
  61. Dika E, Lambertini M, Patrizi A, Misciali C, Altimari A, Fiorentino M, Melotti B, Corti B, Riefolo M, Veronesi G. Frequency of somatic mutations in head and neck melanoma: A single-institution experience. Pigment Cell Melanoma Res. 2020 05; 33(3):515-517. PMID: 31945266.
    Citations: 1     Fields:    Translation:Humans
  62. Giunchi F, Gevaert T, Scarpelli M, Fiorentino M. Status of Programmed Death Ligand 1 (PD-L1) by Immunohistochemistry and Scoring Algorithms. Curr Drug Targets. 2020; 21(13):1286-1292. PMID: 31971109.
    Citations: 3     Fields:    Translation:Humans
  63. Gatto L, Del Gaudio M, Ravaioli M, Cescon M, Tonini V, Cervellera M, Franceschelli A, Pirini MG, Di Scioscio V, Buia F, Niro F, Capizzi E, Fiorentino M, Astolfi A, Indio V, Nannini M, Pantaleo MA, Saponara M. Paratesticular Mesenchymal Malignancies: A Single-Center Case Series, Clinical Management, and Review of Literature. Integr Cancer Ther. 2020 Jan-Dec; 19:1534735419900554. PMID: 32009477.
    Citations: 1     Fields:    Translation:Humans
  64. Vasuri F, Nerpiti A, Zagnoni S, Ravaioli M, D'Errico A, Fiorentino M. Pd-ligand 1 is expressed in inflammatory cells but not in neoplastic cells in hepatocellular carcinoma: An immunohistochemical study. Acta Histochem. 2020 Jan; 122(1):151468. PMID: 31767125.
    Citations: 1     Fields:    Translation:Humans
  65. Bianchi L, Schiavina R, Borghesi M, Chessa F, Casablanca C, Angiolini A, Ercolino A, Pultrone CV, Mineo Bianchi F, Barbaresi U, Piazza P, Manferrari F, Bertaccini A, Fiorentino M, Ferro M, Porreca A, Marcelli E, Brunocilla E. Which patients with clinical localized renal mass would achieve the trifecta after partial nephrectomy? The impact of surgical technique. Minerva Urol Nefrol. 2020 Jun; 72(3):339-349. PMID: 31619030.
    Citations: 5     Fields:    Translation:Humans
  66. Di Nunno V, Mollica V, Brunelli M, Gatto L, Schiavina R, Fiorentino M, Santoni M, Montironi R, Caliò A, Eccher A, Milella M, Martignoni G, Brunocilla E, Massari F. A Meta-Analysis Evaluating Clinical Outcomes of Patients with Renal Cell Carcinoma Harboring Chromosome 9P Loss. Mol Diagn Ther. 2019 10; 23(5):569-577. PMID: 31332726.
    Citations: 5     Fields:    Translation:HumansCells
  67. Labbé DP, Zadra G, Yang M, Reyes JM, Lin CY, Cacciatore S, Ebot EM, Creech AL, Giunchi F, Fiorentino M, Elfandy H, Syamala S, Karoly ED, Alshalalfa M, Erho N, Ross A, Schaeffer EM, Gibb EA, Takhar M, Den RB, Lehrer J, Karnes RJ, Freedland SJ, Davicioni E, Spratt DE, Ellis L, Jaffe JD, D'Amico AV, Kantoff PW, Bradner JE, Mucci LA, Chavarro JE, Loda M, Brown M. High-fat diet fuels prostate cancer progression by rewiring the metabolome and amplifying the MYC program. Nat Commun. 2019 09 25; 10(1):4358. PMID: 31554818.
    Citations: 42     Fields:    Translation:HumansAnimalsCells
  68. Zhang Y, Zhou CK, Rencsok EM, Fall K, Lotan TL, Loda M, Giunchi F, Platz EA, De Marzo AM, Mucci LA, Fiorentino M, Ebot EM. A Prospective Study of Intraprostatic Inflammation, Focal Atrophy, and Progression to Lethal Prostate Cancer. Cancer Epidemiol Biomarkers Prev. 2019 12; 28(12):2047-2054. PMID: 31533941.
    Citations: 3     Fields:    Translation:Humans
  69. Franceschini T, Giunchi F, Montironi R, Scarpelli M, Lopez-Beltran A, Cheng L, Fiorentino M. Liquid biopsies in urological cancers: what we need to know before starting using them. Expert Rev Mol Diagn. 2020 02; 20(2):135-139. PMID: 31509027.
    Citations: 1     Fields:    Translation:HumansCells
  70. Di Nunno V, Mollica V, Schiavina R, Nobili E, Fiorentino M, Brunocilla E, Ardizzoni A, Massari F. Improving IMDC Prognostic Prediction Through Evaluation of Initial Site of Metastasis in Patients With Metastatic Renal Cell Carcinoma. Clin Genitourin Cancer. 2020 04; 18(2):e83-e90. PMID: 31753738.
    Citations: 4     Fields:    Translation:Humans
  71. Livi V, Ardizzoni A, Cancellieri A, Natali F, Ferrari M, Paioli D, De Biase D, Capizzi E, Tallini G, Fiorentino M, Trisolini R. Adequacy of endosonography-derived samples from peribronchial or periesophageal intrapulmonary lesions for the molecular profiling of lung cancer. Clin Respir J. 2019 Sep; 13(9):590-597. PMID: 31343834.
    Citations: 1     Fields:    Translation:Humans
  72. Capizzi E, Dall'Olio FG, Gruppioni E, Sperandi F, Altimari A, Giunchi F, Fiorentino M, Ardizzoni A. Clinical significance of ROS1 5' deletions in non-small cell lung cancer. Lung Cancer. 2019 09; 135:88-91. PMID: 31447007.
    Citations: 3     Fields:    Translation:Humans
  73. Di Nunno V, Mollica V, Santoni M, Gatto L, Schiavina R, Fiorentino M, Brunocilla E, Ardizzoni A, Massari F. New Hormonal Agents in Patients With Nonmetastatic Castration-Resistant Prostate Cancer: Meta-Analysis of Efficacy and Safety Outcomes. Clin Genitourin Cancer. 2019 10; 17(5):e871-e877. PMID: 31378578.
    Citations: 9     Fields:    Translation:Humans
  74. Di Nunno V, Frega G, Santoni M, Gatto L, Fiorentino M, Montironi R, Battelli N, Brandi G, Massari F. BAP1 in solid tumors. Future Oncol. 2019 Jun; 15(18):2151-2162. PMID: 31159579.
    Citations: 8     Fields:    Translation:HumansAnimals
  75. Zelic R, Zugna D, Bottai M, Andrén O, Fridfeldt J, Carlsson J, Davidsson S, Fiano V, Fiorentino M, Giunchi F, Grasso C, Lianas L, Mascia C, Molinaro L, Zanetti G, Richiardi L, Pettersson A, Akre O. Estimation of Relative and Absolute Risks in a Competing-Risks Setting Using a Nested Case-Control Study Design: Example From the ProMort Study. Am J Epidemiol. 2019 06 01; 188(6):1165-1173. PMID: 30976789.
    Citations: 2     Fields:    Translation:Humans
  76. Bianchi L, Schiavina R, Borghesi M, Casablanca C, Chessa F, Mineo Bianchi F, Pultrone C, Vagnoni V, Ercolino A, Dababneh H, Fiorentino M, Brunocilla E. Patterns of positive surgical margins after open radical prostatectomy and their association with clinical recurrence. Minerva Urol Nefrol. 2020 Aug; 72(4):464-473. PMID: 31144486.
    Citations: 4     Fields:    Translation:Humans
  77. Urbini M, Indio V, Tarantino G, Ravegnini G, Angelini S, Nannini M, Saponara M, Santini D, Ceccarelli C, Fiorentino M, Vincenzi B, Fumagalli E, Casali PG, Grignani G, Pession A, Ardizzoni A, Astolfi A, Pantaleo MA. Gain of FGF4 is a frequent event in KIT/PDGFRA/SDH/RAS-P WT GIST. Genes Chromosomes Cancer. 2019 09; 58(9):636-642. PMID: 30887595.
    Citations: 8     Fields:    Translation:HumansCells
  78. Carlsson J, Christiansen J, Davidsson S, Giunchi F, Fiorentino M, Sundqvist P. The potential role of miR-126, miR-21 and miR-10b as prognostic biomarkers in renal cell carcinoma. Oncol Lett. 2019 May; 17(5):4566-4574. PMID: 30988818.
    Citations: 8     
  79. Ahearn TU, Peisch S, Pettersson A, Ebot EM, Zhou CK, Graff RE, Sinnott JA, Fazli L, Judson GL, Bismar TA, Rider JR, Gerke T, Chan JM, Fiorentino M, Flavin R, Sesso HD, Finn S, Giovannucci EL, Gleave M, Loda M, Li Z, Pollak M, Mucci LA. Expression of IGF/insulin receptor in prostate cancer tissue and progression to lethal disease. Carcinogenesis. 2018 12 31; 39(12):1431-1437. PMID: 30165429.
    Citations: 14     Fields:    Translation:HumansCells
  80. Carlsson J, Davidsson S, Fridfeldt J, Giunchi F, Fiano V, Grasso C, Zelic R, Richiardi L, Andrén O, Pettersson A, Fiorentino M, Akre O. Quantity and quality of nucleic acids extracted from archival formalin fixed paraffin embedded prostate biopsies. BMC Med Res Methodol. 2018 12 05; 18(1):161. PMID: 30518332.
    Citations: 5     Fields:    Translation:Humans
  81. Giunchi F, Cimadamore A, Fiorentino M. Emerging Molecular Technologies in Genitourinary Tumors. Front Oncol. 2018; 8:489. PMID: 30425967.
    Citations: 1     
  82. Capizzi E, Ricci C, Giunchi F, Zagnoni S, Ceccarelli C, Gómez BUÁ, Casolari L, Gelsomino F, Trisolini R, Fiorentino M, Ardizzoni A. Validation of the immunohistochemical expression of programmed death ligand 1 (PD-L1) on cytological smears in advanced non small cell lung cancer. Lung Cancer. 2018 12; 126:9-14. PMID: 30527198.
    Citations: 10     Fields:    Translation:Humans
  83. Pernar CH, Ebot EM, Pettersson A, Graff RE, Giunchi F, Ahearn TU, Gonzalez-Feliciano AG, Markt SC, Wilson KM, Stopsack KH, Gazeeva E, Lis RT, Parmigiani G, Rimm EB, Finn SP, Giovannucci EL, Fiorentino M, Mucci LA. A Prospective Study of the Association between Physical Activity and Risk of Prostate Cancer Defined by Clinical Features and TMPRSS2:ERG. Eur Urol. 2019 07; 76(1):33-40. PMID: 30301696.
    Citations: 12     Fields:    Translation:Humans
  84. Rihawi K, Alfieri R, Fiorentino M, Fontana F, Capizzi E, Cavazzoni A, Terracciano M, La Monica S, Ferrarini A, Buson G, Petronini PG, Ardizzoni A. MYC Amplification as a Potential Mechanism of Primary Resistance to Crizotinib in ALK-Rearranged Non-Small Cell Lung Cancer: A Brief Report. Transl Oncol. 2019 Jan; 12(1):116-121. PMID: 30290287.
    Citations: 21     
  85. Isidori F, Malvi D, Fittipaldi S, Forcato C, Bozzarelli I, Sala C, Raulli G, D'Errico A, Fiorentino M, Seri M, Krishnadath KK, Bonora E, Mattioli S. Genomic profiles of primary and metastatic esophageal adenocarcinoma identified via digital sorting of pure cell populations: results from a case report. BMC Cancer. 2018 Sep 12; 18(1):889. PMID: 30208867.
    Citations:    Fields:    Translation:Humans
  86. Di Nunno V, Cimadamore A, Santoni M, Scarpelli M, Fiorentino M, Ciccarese C, Iacovelli R, Cheng L, Lopez-Beltran A, Massari F, Montironi R. Biological issues with cabozantinib in bone metastatic renal cell carcinoma and castration-resistant prostate cancer. Future Oncol. 2018 Oct; 14(25):2559-2564. PMID: 30141348.
    Citations: 3     Fields:    Translation:Humans
  87. Davidsson S, Carlsson J, Giunchi F, Harlow A, Kirrander P, Rider J, Fiorentino M, Andrén O. PD-L1 Expression in Men with Penile Cancer and its Association with Clinical Outcomes. Eur Urol Oncol. 2019 03; 2(2):214-221. PMID: 31017099.
    Citations: 8     Fields:    Translation:HumansCells
  88. Giunchi F, Degiovanni A, Daddi N, Trisolini R, Dell'Amore A, Agostinelli C, Ardizzoni A, Fiorentino M. Fading With Time of PD-L1 Immunoreactivity in Non-Small Cells Lung Cancer Tissues: A Methodological Study. Appl Immunohistochem Mol Morphol. 2018 08; 26(7):489-494. PMID: 27801735.
    Citations: 14     Fields:    Translation:HumansCells
  89. Giunchi F, Fiorentino M, Loda M. The Metabolic Landscape of Prostate Cancer. Eur Urol Oncol. 2019 02; 2(1):28-36. PMID: 30929843.
    Citations: 28     Fields:    Translation:Humans
  90. DuPre NC, Flavin R, Sfanos KS, Unger RH, To S, Gazeeva E, Fiorentino M, De Marzo AM, Rider JR, Mucci LA. Corpora amylacea in prostatectomy tissue and associations with molecular, histological, and lifestyle factors. Prostate. 2018 11; 78(15):1172-1180. PMID: 30009541.
    Citations: 5     Fields:    Translation:Humans
  91. Vasuri F, Visani M, Acquaviva G, Brand T, Fiorentino M, Pession A, Tallini G, D'Errico A, de Biase D. Role of microRNAs in the main molecular pathways of hepatocellular carcinoma. World J Gastroenterol. 2018 Jul 07; 24(25):2647-2660. PMID: 29991871.
    Citations: 32     Fields:    Translation:HumansCells
  92. Grabowska B, Ulvskog E, Carlsson J, Fiorentino M, Giunchi F, Lindblad P, Sundqvist P. Clinical outcome and time trends of surgically treated renal cell carcinoma between 1986 and 2010: results from a single centre in Sweden. Scand J Urol. 2018 Jun; 52(3):206-212. PMID: 29972347.
    Citations: 2     Fields:    Translation:Humans
  93. Cimadamore A, Gasparrini S, Santoni M, Cheng L, Lopez-Beltran A, Battelli N, Massari F, Giunchi F, Fiorentino M, Scarpelli M, Montironi R. Biomarkers of aggressiveness in genitourinary tumors with emphasis on kidney, bladder, and prostate cancer. Expert Rev Mol Diagn. 2018 07; 18(7):645-655. PMID: 29912582.
    Citations: 13     Fields:    Translation:Humans
  94. Schiavina R, Bianchi L, Mineo Bianchi F, Borghesi M, Pultrone CV, Dababneh H, Castellucci P, Ceci F, Nanni C, Gaudiano C, Fiorentino M, Porreca A, Chessa F, Minervini A, Fanti S, Brunocilla E. Preoperative Staging With 11C-Choline PET/CT Is Adequately Accurate in Patients With Very High-Risk Prostate Cancer. Clin Genitourin Cancer. 2018 08; 16(4):305-312.e1. PMID: 29859737.
    Citations: 4     Fields:    Translation:Humans
  95. Vasuri F, Fittipaldi S, De Pace V, Gramantieri L, Bertuzzo V, Cescon M, Pinna AD, Fiorentino M, D'Errico A, Ravaioli M. Tissue miRNA 483-3p expression predicts tumor recurrence after surgical resection in histologically advanced hepatocellular carcinomas. Oncotarget. 2018 Apr 03; 9(25):17895-17905. PMID: 29707155.
    Citations: 2     Fields:    
  96. Schiavina R, Bianchi L, Borghesi M, Dababneh H, Chessa F, Pultrone CV, Angiolini A, Gaudiano C, Porreca A, Fiorentino M, De Groote R, D'Hondt F, De Naeyer G, Mottrie A, Brunocilla E. MRI Displays the Prostatic Cancer Anatomy and Improves the Bundles Management Before Robot-Assisted Radical Prostatectomy. J Endourol. 2018 04; 32(4):315-321. PMID: 29256639.
    Citations: 21     Fields:    Translation:Humans
  97. Ambrosi F, Fiorentino M, Chessa F, Brunocilla E, D'Errico A, Bertuzzo RV, Giunchi F. Persistent Mullerian duct syndrome: Report of two cases with phenotypical immunohistochemical profiling. Urologia. 2018 Nov; 85(4):177-181. PMID: 30426882.
    Citations:    Fields:    Translation:Humans
  98. Ricci C, Rossi MS, De Stefano R, Fiorentino M, Vasuri F. Unusual metastatic localization to the kidney of basaloid squamous cell carcinoma of the oropharynx. Urologia. 2018 Nov; 85(4):182-185. PMID: 30426881.
    Citations:    Fields:    Translation:Humans
  99. Indio V, Astolfi A, Tarantino G, Urbini M, Patterson J, Nannini M, Saponara M, Gatto L, Santini D, do Valle IF, Castellani G, Remondini D, Fiorentino M, von Mehren M, Brandi G, Biasco G, Heinrich MC, Pantaleo MA. Integrated Molecular Characterization of Gastrointestinal Stromal Tumors (GIST) Harboring the Rare D842V Mutation in PDGFRA Gene. Int J Mol Sci. 2018 Mar 04; 19(3). PMID: 29510530.
    Citations: 12     Fields:    Translation:HumansCells
  100. Rihawi K, Cinausero M, Fiorentino M, Salvagni S, Brocchi S, Ardizzoni A. Co-alteration of c-Met and ROS1 in Advanced NSCLC: ROS1 Wins. J Thorac Oncol. 2018 03; 13(3):e41-e43. PMID: 29472059.
    Citations: 2     Fields:    Translation:Humans
  101. Massari F, Di Nunno V, Cubelli M, Santoni M, Fiorentino M, Montironi R, Cheng L, Lopez-Beltran A, Battelli N, Ardizzoni A. Immune checkpoint inhibitors for metastatic bladder cancer. Cancer Treat Rev. 2018 Mar; 64:11-20. PMID: 29407369.
    Citations: 33     Fields:    Translation:HumansAnimals
  102. Massari F, Di Nunno V, Comito F, Cubelli M, Ciccarese C, Iacovelli R, Fiorentino M, Montironi R, Ardizzoni A. Circulating tumor cells in genitourinary tumors. Ther Adv Urol. 2018 Feb; 10(2):65-77. PMID: 29434674.
    Citations: 6     
  103. Graff RE, Ahearn TU, Pettersson A, Ebot EM, Gerke T, Penney KL, Wilson KM, Markt SC, Pernar CH, Gonzalez-Feliciano AG, Song M, Lis RT, Schmidt DR, Vander Heiden MG, Fiorentino M, Giovannucci EL, Loda M, Mucci LA. Height, Obesity, and the Risk of TMPRSS2:ERG-Defined Prostate Cancer. Cancer Epidemiol Biomarkers Prev. 2018 02; 27(2):193-200. PMID: 29167279.
    Citations: 8     Fields:    Translation:Humans
  104. Campana D, Walter T, Pusceddu S, Gelsomino F, Graillot E, Prinzi N, Spallanzani A, Fiorentino M, Barritault M, Dall'Olio F, Brighi N, Biasco G. Correlation between MGMT promoter methylation and response to temozolomide-based therapy in neuroendocrine neoplasms: an observational retrospective multicenter study. Endocrine. 2018 06; 60(3):490-498. PMID: 29150792.
    Citations: 25     Fields:    Translation:HumansCells
  105. Davidsson S, Andren O, Ohlson AL, Carlsson J, Andersson SO, Giunchi F, Rider JR, Fiorentino M. FOXP3+ regulatory T cells in normal prostate tissue, postatrophic hyperplasia, prostatic intraepithelial neoplasia, and tumor histological lesions in men with and without prostate cancer. Prostate. 2018 Jan; 78(1):40-47. PMID: 29105795.
    Citations: 21     Fields:    Translation:HumansCells
  106. Serra C, Rizzello F, Pratico' C, Felicani C, Fiorini E, Brugnera R, Mazzotta E, Giunchi F, Fiorentino M, D'Errico A, Morselli-Labate AM, Mastroroberto M, Campieri M, Poggioli G, Gionchetti P. Real-time elastography for the detection of fibrotic and inflammatory tissue in patients with stricturing Crohn's disease. J Ultrasound. 2017 Dec; 20(4):273-284. PMID: 29204231.
    Citations: 8     Fields:    Translation:Humans
  107. Giunchi F, Ciccarese C, Montironi R, Scarpelli M, Lopez-Beltran A, Cheng L, Moch H, Massari F, Fiorentino M. Urinary Biomarkers for Prostate Cancer. Curr Drug Metab. 2017 Oct 16; 18(8):723-726. PMID: 28524004.
    Citations: 3     Fields:    Translation:Humans
  108. Mann SA, Lopez-Beltran A, Massari F, Pili R, Fiorentino M, Koch MO, Kaimakliotis HZ, Wang L, Scarpelli M, Ciccarese C, Moch H, Montironi R, Cheng L. Targeting the Programmed Cell Death-1 Pathway in Genitourinary Tumors: Current Progress and Future Perspectives. Curr Drug Metab. 2017 Oct 16; 18(8):700-711. PMID: 28524003.
    Citations: 7     Fields:    Translation:HumansAnimalsCells
  109. Rostami K, Marsh MN, Johnson MW, Mohaghegh H, Heal C, Holmes G, Ensari A, Aldulaimi D, Bancel B, Bassotti G, Bateman A, Becheanu G, Bozzola A, Carroccio A, Catassi C, Ciacci C, Ciobanu A, Danciu M, Derakhshan MH, Elli L, Ferrero S, Fiorentino M, Fiorino M, Ganji A, Ghaffarzadehgan K, Going JJ, Ishaq S, Mandolesi A, Mathews S, Maxim R, Mulder CJ, Neefjes-Borst A, Robert M, Russo I, Rostami-Nejad M, Sidoni A, Sotoudeh M, Villanacci V, Volta U, Zali MR, Srivastava A. ROC-king onwards: intraepithelial lymphocyte counts, distribution & role in coeliac disease mucosal interpretation. Gut. 2017 12; 66(12):2080-2086. PMID: 28893865.
    Citations: 17     Fields:    Translation:HumansCells
  110. Tyekucheva S, Bowden M, Bango C, Giunchi F, Huang Y, Zhou C, Bondi A, Lis R, Van Hemelrijck M, Andrén O, Andersson SO, Watson RW, Pennington S, Finn SP, Martin NE, Stampfer MJ, Parmigiani G, Penney KL, Fiorentino M, Mucci LA, Loda M. Stromal and epithelial transcriptional map of initiation progression and metastatic potential of human prostate cancer. Nat Commun. 2017 09 04; 8(1):420. PMID: 28871082.
    Citations: 43     Fields:    Translation:HumansCells
  111. Rihawi K, Gelsomino F, Sperandi F, Melotti B, Fiorentino M, Casolari L, Ardizzoni A. Pembrolizumab in the treatment of metastatic non-small cell lung cancer: a review of current evidence. Ther Adv Respir Dis. 2017 09; 11(9):353-373. PMID: 28818019.
    Citations: 10     Fields:    Translation:Humans
  112. Massari F, Ciccarese C, Hes O, Michal M, Caliò A, Fiorentino M, Giunchi F, D'Amuri A, Sanguedolce F, Sabbatini R, Guida A, Ardizzoni A, Porta C, Iacovelli R, Tortora G, Cima L, Ortega C, Lapini A, Martignoni G, Brunelli M. The Tumor Entity Denominated "clear cell-papillary renal cell carcinoma" According to the WHO 2016 new Classification, have the Clinical Characters of a Renal Cell Adenoma as does Harbor a Benign Outcome. Pathol Oncol Res. 2018 Jul; 24(3):447-456. PMID: 28695322.
    Citations: 4     Fields:    Translation:Humans
  113. Dika E, Fanti PA, Vaccari S, Capizzi E, Degiovanni A, Gobbi A, Piraccini BM, Ribero S, Baraldi C, Ravaioli GM, Fiorentino M, Patrizi A. Oestrogen and progesterone receptors in melanoma and nevi: an immunohistochemical study. Eur J Dermatol. 2017 Jun 01; 27(3):254-259. PMID: 28524047.
    Citations: 5     Fields:    Translation:HumansCells
  114. Giunchi F, Jordahl K, Bollito E, Colecchia M, Patriarca C, D'Errico A, Vasuri F, Malvi D, Fornari A, Bonetti LR, Corti B, Papotti M, DeGiuli P, Loda M, Montironi R, Fiorentino M, Rider JR. Interpathologist concordance in the histological diagnosis of focal prostatic atrophy lesions, acute and chronic prostatitis, PIN, and prostate cancer. Virchows Arch. 2017 Jun; 470(6):711-715. PMID: 28405833.
    Citations: 2     Fields:    Translation:Humans
  115. Agostinelli C, Carloni S, Limarzi F, Righi S, Laginestra MA, Musuraca G, Fiorentino M, Napolitano R, Cuneo A, Vergara D, Zinzani PL, Sabattini E, Pileri SA, De Matteis S. The emerging role of GSK-3ß in the pathobiology of classical Hodgkin lymphoma. Histopathology. 2017 Jul; 71(1):72-80. PMID: 28208230.
    Citations: 5     Fields:    Translation:HumansCells
  116. Zuntini R, Cortesi L, Calistri D, Pippucci T, Martelli PL, Casadio R, Capizzi E, Santini D, Miccoli S, Medici V, Danesi R, Marchi I, Zampiga V, Fiorentino M, Ferrari S, Turchetti D. BRCA1 p.His1673del is a pathogenic mutation associated with a predominant ovarian cancer phenotype. Oncotarget. 2017 Apr 04; 8(14):22640-22648. PMID: 28186987.
    Citations: 5     Fields:    Translation:Humans
  117. Ciccarese C, Massari F, Iacovelli R, Fiorentino M, Montironi R, Di Nunno V, Giunchi F, Brunelli M, Tortora G. Prostate cancer heterogeneity: Discovering novel molecular targets for therapy. Cancer Treat Rev. 2017 Mar; 54:68-73. PMID: 28231559.
    Citations: 33     Fields:    Translation:HumansCells
  118. Fiorentino M, Gruppioni E, Massari F, Giunchi F, Altimari A, Ciccarese C, Bimbatti D, Scarpa A, Iacovelli R, Porta C, Virinder S, Tortora G, Artibani W, Schiavina R, Ardizzoni A, Brunelli M, Knuutila S, Martignoni G. Wide spetcrum mutational analysis of metastatic renal cell cancer: a retrospective next generation sequencing approach. Oncotarget. 2017 Jan 31; 8(5):7328-7335. PMID: 27741505.
    Citations: 10     Fields:    Translation:Humans
  119. Graff RE, Judson G, Ahearn TU, Fiorentino M, Loda M, Giovannucci EL, Mucci LA, Pettersson A. Circulating Antioxidant Levels and Risk of Prostate Cancer by TMPRSS2:ERG. Prostate. 2017 May; 77(6):647-653. PMID: 28102015.
    Citations: 5     Fields:    Translation:Humans
  120. Zareba P, Flavin R, Isikbay M, Rider JR, Gerke TA, Finn S, Pettersson A, Giunchi F, Unger RH, Tinianow AM, Andersson SO, Andrén O, Fall K, Fiorentino M, Mucci LA. Perineural Invasion and Risk of Lethal Prostate Cancer. Cancer Epidemiol Biomarkers Prev. 2017 05; 26(5):719-726. PMID: 28062398.
    Citations: 14     Fields:    Translation:Humans
  121. Fiorentino M, Scarpelli M, Lopez-Beltran A, Cheng L, Montironi R. Considerations for standardizing predictive molecular pathology for cancer prognosis. Expert Rev Mol Diagn. 2017 01; 17(1):47-55. PMID: 27897454.
    Citations:    Fields:    Translation:Humans
  122. Giunchi F, Vasuri F, Valerio V, Montagnani I, Nelli F, Fiorentino M, Raspollini MR. Unusual asymptomatic presentation of bladder cancer metastatic to the penis. Pathol Res Pract. 2017 Jun; 213(6):717-720. PMID: 28476381.
    Citations: 2     Fields:    Translation:Humans
  123. Giunchi F, Vasuri F, Colecchia M, Gentile G, Garofalo M, Schiavina R, Fiorentino M. Frozen section analysis of unusual small testicular tumor masses: report of 3 cases. Tumori. 2016 Nov 11; 102(Suppl. 2). PMID: 26893271.
    Citations:    Fields:    Translation:Humans
  124. Sinnott JA, Peisch SF, Tyekucheva S, Gerke T, Lis R, Rider JR, Fiorentino M, Stampfer MJ, Mucci LA, Loda M, Penney KL. Prognostic Utility of a New mRNA Expression Signature of Gleason Score. Clin Cancer Res. 2017 Jan 01; 23(1):81-87. PMID: 27663590.
    Citations: 27     Fields:    Translation:HumansCells
  125. Ceci F, Fiorentino M, Castellucci P, Fanti S. Molecular Imaging and Precision Medicine in Prostate Cancer. PET Clin. 2017 Jan; 12(1):83-92. PMID: 27863569.
    Citations:    Fields:    Translation:Humans
  126. Ciccarese C, Brunelli M, Montironi R, Fiorentino M, Iacovelli R, Heng D, Tortora G, Massari F. The prospect of precision therapy for renal cell carcinoma. Cancer Treat Rev. 2016 Sep; 49:37-44. PMID: 27453294.
    Citations: 22     Fields:    Translation:HumansCells
  127. Yang M, Zu K, Mucci LA, Rider JR, Fiorentino M, Clinton SK, Loda M, Stampfer MJ, Giovannucci E. Vascular morphology differentiates prostate cancer mortality risk among men with higher Gleason grade. Cancer Causes Control. 2016 08; 27(8):1043-7. PMID: 27379990.
    Citations: 3     Fields:    Translation:Humans
  128. Saponara M, Gatto L, Di Nunno V, Tabacchi E, Fanti S, Di Scioscio V, Nannini M, Gruppioni E, Altimari A, Fiorentino M, Santini D, Ceccarelli C, Zompatori M, Biasco G, Pantaleo MA. Successful treatment with personalized dosage of imatinib in elderly patients with gastrointestinal stromal tumors. Anticancer Drugs. 2016 Apr; 27(4):353-63. PMID: 26720290.
    Citations: 2     Fields:    Translation:Humans
  129. Graff RE, Meisner A, Ahearn TU, Fiorentino M, Loda M, Giovannucci EL, Mucci LA, Pettersson A. Pre-diagnostic circulating sex hormone levels and risk of prostate cancer by ERG tumour protein expression. Br J Cancer. 2016 Apr 12; 114(8):939-44. PMID: 26986253.
    Citations: 11     Fields:    Translation:Humans
  130. Farina E, Monari F, Tallini G, Repaci A, Mazzarotto R, Giunchi F, Panzacchi R, Cammelli S, Padula GD, Deodato F, Pasquali R, Fanti S, Fiorentino M, Morganti AG. Unusual Thyroid Carcinoma Metastases: a Case Series and Literature Review. Endocr Pathol. 2016 Mar; 27(1):55-64. PMID: 26662609.
    Citations: 27     Fields:    Translation:Humans
  131. Graff RE, Pettersson A, Lis RT, Ahearn TU, Markt SC, Wilson KM, Rider JR, Fiorentino M, Finn S, Kenfield SA, Loda M, Giovannucci EL, Rosner B, Mucci LA. Dietary lycopene intake and risk of prostate cancer defined by ERG protein expression. Am J Clin Nutr. 2016 Mar; 103(3):851-60. PMID: 26817504.
    Citations: 33     Fields:    Translation:HumansAnimals
  132. Giunchi F, Panzacchi R, Capizzi E, Schiavina R, Brunocilla E, Martorana G, D'Errico A, Fiorentino M. Role of Inter-Observer Variability and Quantification of Muscularis Propria in the Pathological Staging of Bladder Cancer. Clin Genitourin Cancer. 2016 08; 14(4):e307-12. PMID: 26874973.
    Citations: 1     Fields:    Translation:Humans
  133. Thorgeirsson T, Jordahl KM, Flavin R, Epstein MM, Fiorentino M, Andersson SO, Andren O, Rider JR, Mosquera JM, Ingoldsby H, Fall K, Tryggvadottir L, Mucci LA. Intracellular location of BRCA2 protein expression and prostate cancer progression in the Swedish Watchful Waiting Cohort. Carcinogenesis. 2016 Mar; 37(3):262-8. PMID: 26775038.
    Citations: 2     Fields:    Translation:HumansCells
  134. Barbaro MR, Di Sabatino A, Cremon C, Giuffrida P, Fiorentino M, Altimari A, Bellacosa L, Stanghellini V, Barbara G. Interferon-? is increased in the gut of patients with irritable bowel syndrome and modulates serotonin metabolism. Am J Physiol Gastrointest Liver Physiol. 2016 Mar 15; 310(6):G439-47. PMID: 26744473.
    Citations: 16     Fields:    Translation:HumansCells
  135. Giunchi F, Fiorentino M, Vagnoni V, Capizzi E, Bertolo R, Porpiglia F, Vatrano S, Tamberi S, Schiavina R, Papotti M, Bollito E. Renal oncocytosis: a clinicopathological and cytogenetic study of 42 tumours occurring in 11 patients. Pathology. 2016 Jan; 48(1):41-6. PMID: 27020208.
    Citations: 5     Fields:    Translation:Humans
  136. Garajová I, Funel N, Fiorentino M, Agostini V, Ferracin M, Negrini M, Frassineti GL, Gavelli G, Frampton AE, Biasco G, Giovannetti E. MicroRNA profiling of primary pulmonary enteric adenocarcinoma in members from the same family reveals some similarities to pancreatic adenocarcinoma-a step towards personalized therapy. Clin Epigenetics. 2015; 7:129. PMID: 26677401.
    Citations: 9     Fields:    
  137. Saponara M, Urbini M, Astolfi A, Indio V, Ercolani G, Del Gaudio M, Santini D, Pirini MG, Fiorentino M, Nannini M, Lolli C, Mandrioli A, Gatto L, Brandi G, Biasco G, Pinna AD, Pantaleo MA. Molecular characterization of metastatic exon 11 mutant gastrointestinal stromal tumors (GIST) beyond KIT/PDGFRa genotype evaluated by next generation sequencing (NGS). Oncotarget. 2015 Dec 08; 6(39):42243-57. PMID: 26544626.
    Citations: 12     Fields:    Translation:HumansCells
  138. Ahearn TU, Pettersson A, Ebot EM, Gerke T, Graff RE, Morais CL, Hicks JL, Wilson KM, Rider JR, Sesso HD, Fiorentino M, Flavin R, Finn S, Giovannucci EL, Loda M, Stampfer MJ, De Marzo AM, Mucci LA, Lotan TL. A Prospective Investigation of PTEN Loss and ERG Expression in Lethal Prostate Cancer. J Natl Cancer Inst. 2016 Feb; 108(2). PMID: 26615022.
    Citations: 76     Fields:    Translation:Humans
  139. Zanirato Rambaldi G, Monari F, Fiorentino M, Cammelli S, Repaci A, Cremonini N, Cavicchi O, Caliceti U, Farina E, Deodato F, Di Fabio F, Presutti L, Fanti S, Frezza GP, Morganti AG. Complete pathological response after chemo-radiation in anaplastic thyroid cancer: A report of two cases. Acta Oncol. 2016; 55(4):530-2. PMID: 26523660.
    Citations: 1     Fields:    Translation:Humans
  140. Lu D, Sinnott JA, Valdimarsdóttir U, Fang F, Gerke T, Tyekucheva S, Fiorentino M, Lambe M, Sesso HD, Sweeney CJ, Wilson KM, Giovannucci EL, Loda M, Mucci LA, Fall K. Stress-Related Signaling Pathways in Lethal and Nonlethal Prostate Cancer. Clin Cancer Res. 2016 Feb 01; 22(3):765-772. PMID: 26490316.
    Citations: 10     Fields:    Translation:HumansCells
  141. Dika E, Fanti PA, Fiorentino M, Capizzi E, Neri I, Piraccini BM, Ravaioli GM, Misciali C, Passarini B, Patrizi A. Spitzoid tumors in children and adults: a comparative clinical, pathological, and cytogenetic analysis. Melanoma Res. 2015 Aug; 25(4):295-301. PMID: 25933206.
    Citations: 5     Fields:    Translation:HumansCells
  142. Martin NE, Gerke T, Sinnott JA, Stack EC, Andrén O, Andersson SO, Johansson JE, Fiorentino M, Finn S, Fedele G, Stampfer M, Kantoff PW, Mucci LA, Loda M. Measuring PI3K Activation: Clinicopathologic, Immunohistochemical, and RNA Expression Analysis in Prostate Cancer. Mol Cancer Res. 2015 Oct; 13(10):1431-40. PMID: 26124442.
    Citations: 10     Fields: